论文信息 - Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA‐HF Trials - 字舞流文

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA‐HF Trials

P. Jhund | M. Vaduganathan | O. Vardeny | A. Bhatt | Ian J. Kulac | B. Claggett | Sanjiv J. Shah | M. Sabatine | Scott D. Solomon | J. McMurray | J. Fang | Mikhail N. Kosiborod | A. Desai | I. Anand | Thomas A Gaziano | Adrian F Hernandez